Literature DB >> 8461561

Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.

M Neer1, D M Slovik, M Daly, T Potts, S R Nussbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8461561     DOI： 10.1007/bf01621907

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  9 in total

1.  The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).

Authors:  L Mosekilde; C H Søgaard; C C Danielsen; O Tørring
Journal:  Endocrinology       Date:  1991-07       Impact factor: 4.736

2.  Parathyroid hormone and experimental osteosclerosis.

Authors:  D N Kalu; F H Doyle; J Pennock; G V Foster
Journal:  Lancet       Date:  1970-06-27       Impact factor: 79.321

3.  Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone.

Authors:  M Gunness-Hey; J M Hock
Journal:  Metab Bone Dis Relat Res       Date:  1984

4.  Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.

Authors:  A B Hodsman; L J Fraher
Journal:  Bone Miner       Date:  1990-05

5.  Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone.

Authors:  E Hefti; U Trechsel; J P Bonjour; H Fleisch; R Schenk
Journal:  Clin Sci (Lond)       Date:  1982-04       Impact factor: 6.124

6.  Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds.

Authors:  R Podbesek; C Edouard; P J Meunier; J A Parsons; J Reeve; R W Stevenson; J M Zanelli
Journal:  Endocrinology       Date:  1983-03       Impact factor: 4.736

7.  Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.

Authors:  D M Slovik; D I Rosenthal; S H Doppelt; J T Potts; M A Daly; J A Campbell; R M Neer
Journal:  J Bone Miner Res       Date:  1986-08       Impact factor: 6.741

8.  Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration.

Authors:  C S Tam; J N Heersche; T M Murray; J A Parsons
Journal:  Endocrinology       Date:  1982-02       Impact factor: 4.736

9.  Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.

Authors:  J Reeve; P J Meunier; J A Parsons; M Bernat; O L Bijvoet; P Courpron; C Edouard; L Klenerman; R M Neer; J C Renier; D Slovik; F J Vismans; J T Potts
Journal:  Br Med J       Date:  1980-06-07
  9 in total
  7 in total

Review 1.  Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.

Authors:  J Y Reginster; A N Taquet; G Fraikin; C Gosset; B Zegels
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin).

Authors:  J F Whitfield; P Morley; G E Willick; V Ross; J R Barbier; R J Isaacs; L Ohannessian-Barry
Journal:  Calcif Tissue Int       Date:  1996-02       Impact factor: 4.333

Review 3.  Parathyroid hormone and its receptor gene polymorphisms: implications in osteoporosis and in fracture healing.

Authors:  Shahryar Noordin; Julie Glowacki
Journal:  Rheumatol Int       Date:  2015-07-21       Impact factor: 2.631

4.  Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.

Authors:  Yang Yang; Ali Aghazadeh-Habashi; Arash Panahifar; Yuchin Wu; Krishna H Bhandari; Michael R Doschak
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

5.  Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

Authors:  N E Lane; S Sanchez; G W Modin; H K Genant; E Pierini; C D Arnaud
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

Review 6.  The use of intermittent human parathyroid hormone as a treatment for osteoporosis.

Authors:  Chad Deal
Journal:  Curr Rheumatol Rep       Date:  2004-02       Impact factor: 4.592

Review 7.  The Effect of Teriparatide on the Hip: A Literature Review.

Authors:  Kwangkyoun Kim; Ye-Yeon Won; Seok-Won Lee; Kyung-Deok Seo
Journal:  Hip Pelvis       Date:  2021-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.